We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur, Koni
The rapid emergence of antimicrobial resistance has become a major global health concern, reducing the effectiveness of conventional antibiotics and increasing the need for safer and more effective alternatives. Medicinal plants are recognized as rich sources of bioactive phytoconstituents with significant antimicrobial potential against a wide range of pathogenic microorganisms. Various plant-derived compounds, including alkaloids, flavonoids, terpenoids, tannins, phenolics, saponins, and essential oils, have demonstrated the ability to inhibit microbial growth through diverse mechanisms such as disruption of cell membranes, inhibition of enzyme activity, suppression of nucleic acid synthesis, and prevention of biofilm formation. Numerous medicinal plants such as Curcuma longa, Azadirachta indica, Allium sativum, and Ocimum sanctum have shown promising antibacterial, antifungal, and antiviral activities against resistant microbial strains. In addition to their antimicrobial effects, these phytoconstituents often exhibit antioxidant and anti-inflammatory properties, enhancing their therapeutic significance. Recent advancements in herbal drug delivery systems and phytopharmaceutical research have further improved the efficacy and applicability of plant-based antimicrobial agents. However, issues related to standardization, safety evaluation, and clinical validation still require extensive investigation. This review aims to summarize the antimicrobial potential of bioactive phytoconstituents from medicinal plants, their mechanisms of action, and their future prospects as natural alternatives for combating microbial infections and antimicrobial resistance.
Antimicrobial resistance (AMR), a growing menace due to over-reliance and misuse of common antibiotics, is increasingly becoming a global health problem, thus requiring new strategies to tackle infectious diseases. The use of common drugs to cure diseases is causing an evolution of microorganisms, leading to increased resistance towards these drugs. This trend poses a big threat to modern-day medicine by jeopardizing the gains made in managing infections caused by bacteria, fungi, viruses, and parasites. Thus, the search for antimicrobial agents is gaining momentum in order to solve this problem, which is fueling efforts aimed at harnessing medicinal properties of plants to isolate new bioactive compounds. Medicinal herbs have been commonly used across the globe in ancient medical practices for many years because of their inherent value, indicating their medicinal value. Through the study of phytoconstituents responsible for providing medicinal benefits, including powerful Anti-bacterial actions, modern research is helping validate the effectiveness of these methods. These bioactive compounds offer diverse chemical profiles that are capable of fighting microbes through different mechanisms, thus acting as potent alternatives and supplements to antimicrobial medications. The essay will analyze the relevance of bioactive phytoconstituents in medicinal plants as potential antimicrobial drugs.
1.2. The Chemical Diversity of Antimicrobial Phytoconstituents
There are numerous secondary metabolites, some of which display extraordinary biological actions, in medicinal plants. One major group of these chemicals possesses significant Anti-bacterial properties against different harmful organisms. This is due to their diverse chemical structure, which results in various types of action.
Alkaloids are a group of organic compounds with high nitrogen content. There are numerous alkaloids that possess significant actions against different microorganisms. For example, berberine alkaloids isolated from Hydrastis canadensis (goldenseal) and Berberis vulgaris (barberry) exhibit remarkable actions against different kinds of Gram-positive and Gram-negative bacteria and fungi. The Anti-bacterial mechanism of berberine is based on its intercalating into bacterial DNA, inhibiting protein synthesis, and interfering with cell membrane functions. Another alkaloid is sanguinarine, isolated from Sanguinaria canadensis, which has been shown to possess broad-spectrum Anti-bacterial and anti-inflammatory actions.
Another equally significant group of phytoconstituents which have strong antimicrobial actions is the phenolic group. These compounds contain at least one hydroxyl group which is directly attached to an aromatic ring. Flavonoids (such as quercetin, kaempferol, apigenin), tannins, and phenolic acids belong to this group. Antimicrobial actions of these flavonoids can be attributed to inhibition of microbial enzyme actions, disruption of cellular membranes, and prevention of biofilm formation. An example is phloroglucinol, a flavonoid found in various plants, like Hypericum perforatum (St. John's wort), which has proven effective against Staphylococcus aureus and even its resistant forms like MRSA. The tannins are known astringent agents because these polymeric phenolics precipitate microbial proteins, making them inactive. Besides that, these phenolic agents may attach themselves to the microbial cell wall, causing leakage and cell death. Sources of tannins include oak bark and tea leaves.
Another important class of compounds is terpenoids, which consist of a group of isoprene compounds. Monoterpenes, sesquiterpenes, diterpenes, and triterpenes are some of the terpenoids that possess antimicrobial properties. Essential oils such as those of thyme and oregano contain thymol and carvacrol respectively. These oils exhibit very strong Anti-bacterial and antifungal effects due to their lipophilicity causing increased membrane permeability and cell death. Some sesquiterpenes like artemisinin found in Artemisia annua besides their antimalarial effects also exhibit antimicrobial properties.
Antimicrobial action in plants is further enhanced by glycosides; glycosides are molecules formed by the connection of sugars to other molecules that do not contain sugars. Saponins found in liquorice (Glycyrrhiza glabra) are examples of glycosides which have soaplike characteristics. They can cause hole formation in cells through binding to sterols in microbial membranes. Glycosides found in Sambucus nigra are capable of preventing viral replication and hence exhibit antiviral properties.
Finally, polypeptides and proteins may also function as antimicrobials despite the lack of frequent references. Defensins are one such example; they are a group of cysteine-containing antimicrobial peptides that can create pores within microbes. Furthermore, lectins can exert antimicrobial activity since they inhibit cell-to-cell interaction via carbohydrate binding.
One major strength of these phytoconstituents lies within their diverse chemical structure. This indicates not only the ability to affect multiple targets but also a reduced chance of resistance when compared to traditional single-target drugs. Another advantage of this diversity is the potential synergy that may occur between different substances within a single plant extract.
2. Mechanisms of Action of Antimicrobial Phytoconstituents
Different mechanisms through which antimicrobial plant constituents can produce their effect have been identified based on their different structural features. It is important to comprehend how the different molecules inhibit or kill pathogens, because the information can be very useful when designing antimicrobial molecules or forecasting resistance mechanisms. One of the most frequently employed mechanisms is associated with interference with microbial cell membrane function. The lipid bilayer of the cell membrane is susceptible to various lipophilic compounds, such as terpenoids and phenolics in essential oils. They permeate the cell membrane and disturb its structure and function, which results in higher permeability, loss of intracellular contents (such as ions, ATP, proteins), and eventually cell death.
The next mechanism that is considered very important for Anti-bacterial activity includes enzyme inhibition. Microbial survival and reproduction are dependent on numerous enzymes, such as those taking part in cell wall formation, DNA replication, protein formation, and energy production. Such enzymes can be inhibited by phytoconstituents by their binding with the active center of enzymes. Flavonoids have proved to effectively inhibit reverse transcriptase in viruses and beta-lactamase enzymes in bacteria that ensure antibiotic resistance. One study has revealed the ability of quercetin to inhibit bacterial DNA gyrase.
Nucleic acid synthesis interference also plays an important role. There are some constituents capable of interacting with nucleic acids and thus stopping DNA replication and RNA transcription. As discussed above, berberine is capable of intercalation into DNA double helix and thus preventing DNA replication. Moreover, there are compounds that inhibit the activity of nucleic acid synthesizing enzymes.
Protein synthesis is another potential target. Specific types of phytochemicals have the ability to react with microorganisms’ ribosomes, thus hampering their translation of messenger RNA into proteins. This would cause the formation of malfunctioning proteins or even inhibition of protein synthesis, which is required for the growth and sustenance of microbes.
A third important target for phytochemicals is cell wall synthesis, especially for bacteria. The bacterial cell wall mainly consists of peptidoglycan and gives the microbe strength. Any substance which could interfere with the enzymatic reactions that synthesize peptidoglycan, such as transpeptidation, would make the cell wall weak resulting in cell death due to osmotic lysis, especially under hypotonic conditions. While this mechanism forms the basis for several synthesized beta-lactams, some substances obtained from natural plants might also affect it in various ways. Several other phytoconstituents work by forming chelates with metals required as cofactors of microbial enzymes.
Many antimicrobial peptides and proteins such as plant defensins exert their Anti-bacterial action through pore-forming action in microbial cell membranes, causing death of bacteria within a few seconds or minutes. The pore formed by defensin molecules selectively interferes with the electrochemical potential of the microbial cell.
These mechanisms may become even more complex as some molecules are involved in interfering with bacterial quorum sensing system – chemical signals coordinating bacterial behavior in groups. Bacterial quorum sensing systems are critical for coordination of processes such as biofilm creation, virulence factors secretion, etc. Antimicrobial action by such mechanism does not involve direct damage to bacteria, but simply interferes with communication and can render them harmless.
Another aspect worth mentioning about natural Anti-bacterial substances is that they usually contain several molecules with synergic effects; their combined influence is higher than expected based on additive properties. Synergic antimicrobial agents are effective against a broad range of pathogens and also capable of overcoming resistance mechanisms.
Figure No.1: Representing Some of the prominent herbal plants and their phytoconstituents exhibiting antimicrobial activity.
5. Therapeutic Applications and Potential of Bioactive Phytoconstituents
The diverse antimicrobial activities exhibited by bioactive phytoconstituents offer a wide range of potential therapeutic applications, particularly in combating drug-resistant pathogens and in areas where conventional antibiotics are less accessible or have limited efficacy. Infections caused by multidrug-resistant bacteria, such as MRSA, vancomycin-resistant Enterococci (VRE), and extended-spectrum beta-lactamase (ESBL) producing Gram-negative bacteria, represent a critical unmet medical need. Numerous studies have demonstrated the efficacy of plant extracts and isolated phytoconstituents against these challenging pathogens. For example, the essential oil of Melaleuca alternifolia (tea tree oil), has been investigated for topical use in the treatment of skin infections after demonstrating notable action against MRSA in vitro. Comparably, substances derived from Artemisia annua (sweet wormwood), including as derivatives of artemisinin, have demonstrated potential against bacteria that are resistant to antibiotics.
Fungal infections, particularly invasive candidiasis and aspergillosis, are also a growing concern, especially in immunocompromised individuals. Flavonoids and terpenoids are examples of phytoconstituents that have shown strong antifungal action against a variety of Aspergillus and Candida species. For example, the ethanolic extract of Syzygium aromaticum, or clove, has been studied for its ability to treat oral candidiasis and has demonstrated broad-spectrum antifungal action.
Viral infections remain a significant public health challenge, and the development of new antiviral agents is crucial. Certain plant-derived compounds, such as polyphenols from Sambucus nigra (elderberry) and polysaccharides from mushrooms, have shown antiviral properties, including the ability to inhibit viral replication and entry into host cells. Research into compounds like Tamiflu, which was inspired by natural products, highlights the potential for nature-based drug discovery in antiviral therapy.
Millions of people worldwide are still afflicted by parasitic illnesses including trypanosomiasis, leishmaniasis, and malaria, especially in tropical and subtropical areas. Phytoconstituents from plants like Azadirachta indica (neem) and Artemisia annua (artemisinin for malaria) have long been used to treat parasitic disorders, and their mechanisms and effectiveness are currently being thoroughly investigated. Azadirachtin and other chemicals produced from neem have shown broad-spectrum antiparasitic efficacy.
Beyond direct antimicrobial effects, some phytoconstituents possess immunomodulatory properties that can enhance the host's defense mechanisms against infection. Compounds from Echinacea purpurea, for instance, have been demonstrated to boost immunity, which may help treat infections.
The potential applications are not limited to systemic infections. Topical applications for wound healing, skin infections, and oral hygiene are also promising. Plant extracts with antiseptic and anti-inflammatory properties are already incorporated into a variety of natural health products.
The development of phytoconstituents as antimicrobial agents offers several advantages. Because of their intricate structures, pathogens may find it more difficult to evolve resistance. Although thorough clinical trials are still required, they frequently have a history of safe usage in traditional medicine, indicating a favourable safety profile.Furthermore, their potential for synergy with existing antibiotics could revitalize older drugs or enhance the efficacy of new ones.
Table No.1 Representing Different Phytoconstituents Showing Antimicrobial potency
|
Sr. No. |
Herbal Plant |
Scientific Name |
Major Bioactive Constituents |
Major Micro-organisms Affected |
Proposed Anti-microbial Mechanism |
Type of Activity |
Important Applications |
|
1 |
Turmeric |
Curcuma longa |
Curcumin, dimethoxy-curcumin, volatile oils |
Staphylococcus aureus, Escherichia coli, Candida albicans |
Disrupts microbial membrane integrity, inhibits protein and nucleic acid synthesis, reduces biofilm formation |
Anti-bacterial, anti-fungal |
Wound healing creams, oral care, topical formulations |
|
2 |
Neem |
Azadirachta indica |
Azadirachtin, nimbidin, quercetin |
Salmonella typhi, S. aureus, Aspergillus niger |
Causes membrane damage, enzyme inhibition, and suppression of microbial adhesion |
Anti-bacterial, antifungal |
Skin infections, dental hygiene products |
|
3 |
Garlic |
Allium sativum |
Allicin, ajoene, sulfur compounds |
Helicobacter pylori, E. coli, Candida albicans |
Reacts with thiol-containing enzymes leading to metabolic inhibition |
Anti-bacterial, antifungal, antiviral |
Respiratory infections, food preservation |
|
4 |
Tulsi (Holy Basil) |
Ocimum tenuiflorum |
Eugenol, ursolic acid, rosmarinic acid |
Klebsiella pneumoniae, Pseudomonas aeruginosa |
Induces oxidative stress and disrupts cell membrane permeability |
Anti-bacterial, antiviral |
Herbal teas, immune-support preparations |
|
5 |
Ginger |
Zingiber officinale |
Gingerols, shogaols, zingerone |
E. coli, Bacillus subtilis |
Inhibits quorum sensing and microbial enzyme systems |
Anti-bacterial, antifungal |
Gastro-intestinal remedies, nutraceuticals |
|
6 |
Green Tea |
Camellia sinensis |
Catechins (EGCG), flavonoids |
Streptococcus mutans, influenza virus |
Alters membrane function and inhibits nucleic acid synthesis |
Anti-bacterial, antiviral |
Mouthwash, antioxidant supplements |
|
7 |
Clove |
Syzygium aromaticum |
Eugenol, tannins, flavonoids |
Candida albicans, S. aureus |
Denatures proteins and increases membrane permeability |
Anti-bacterial, antifungal |
Dental analgesics, antiseptic oils |
|
8 |
Cinnamon |
Cinnamomum verum |
Cinnamaldehyde, eugenol |
Listeria monocytogenes, E. coli |
Interferes with ATP production and membrane integrity |
Anti-bacterial, antifungal |
Food preservation, aromatherapy |
|
9 |
Aloe Vera |
Aloe barbadensis Miller |
Anthraquinones, saponins, acemannan |
P. aeruginosa, Candida spp. |
Damages microbial cell wall and inhibits growth signaling pathways |
Anti-bacterial, antifungal |
Burn dressings, dermatological products |
|
10 |
Eucalyptus |
Eucalyptus globulus |
Eucalyptol, terpenoids |
Mycobacterium tuberculosis, S. aureus |
Disrupts lipid membranes and respiratory enzymes |
Anti-bacterial, antiviral |
Inhalants, cough syrups |
|
11 |
Licorice |
Glycyrrhiza glabra |
Glycyrrhizin, liquiritigenin |
H. pylori, herpes simplex virus |
Inhibits viral replication and bacterial enzyme activity |
Anti-bacterial, antiviral |
Gastro-protective and antiviral formulations |
|
12 |
Peppermint |
Mentha piperita |
Menthol, menthone |
E. coli, Candida albicans |
Alters membrane permeability and inhibits toxin production |
Anti-bacterial, antifungal |
Oral hygiene, digestive preparations |
|
13 |
Lemongrass |
Cymbopogon citratus |
Citral, limonene |
S. aureus, Bacillus cereus |
Causes leakage of intracellular components and inhibits biofilms |
Anti-bacterial, antifungal |
Essential oils, disinfectants |
|
14 |
Black Pepper |
Piper nigrum |
Piperine, volatile oils |
E. coli, Salmonella enterica |
Inhibits microbial efflux pumps and metabolic enzymes |
Anti-bacterial |
Food preservation, herbal formulations |
|
15 |
Amla (Indian Gooseberry) |
Phyllanthus emblica |
Gallic acid, ellagic acid, vitamin C |
S. aureus, Shigella dysenteriae |
Generates oxidative imbalance and inhibits microbial growth |
Anti-bacterial, antviral |
Nutraceuticals, immunity boosters |
|
16 |
Ashwa-gandha |
Withania somnifera |
Withanolides, alkaloids |
S. aureus, Candida spp. |
Inhibits microbial protein synthesis and virulence factors |
Anti-bacterial, antifungal |
Adaptogenic and immune-support products |
|
17 |
Rosemary |
Rosmarinus officinalis |
Rosmarinic acid, carnosic acid |
Listeria monocytogenes, E. coli |
Antioxidant-mediated membrane destabilization |
Anti-bacterial, antifungal |
Food preservative, topical products |
|
18 |
Thyme |
Thymus vulgaris |
Thymol, carvacrol |
S. aureus, P. aeruginosa |
Disrupts cytoplasmic membrane and ATP synthesis |
Anti-bacterial, antifungal |
Antiseptic mouthwash, respiratory care |
|
19 |
Oregano |
Origanum vulgare |
Carvacrol, thymol |
E. coli, Salmonella spp. |
Alters membrane fluidity and suppresses microbial metabolism |
Anti-bacterial, antifungal |
Essential oils, food safety applications |
|
20 |
Henna |
Lawsonia inermis |
Lawsone, tannins, flavonoids |
Dermatophytes, S. aureus |
Interferes with DNA replication and fungal cell wall synthesis |
Anti-bacterial, antifungal |
Traditional skin and scalp preparations |
6. Advancements in plant-derived antimicrobials in combating antimicrobial resistance (AMR)
In 2024, Angelini evaluated the significance of antimicrobial plant products for tackling AMR. It was shown that there are various bioactive phytoconstituents, like flavonoids, alkaloids, tannins, terpenoids, and phenols, which provide medicinal plants with wide spectrum activity against pathogens. According to the article, these products operate in terms of microbial membrane destruction, nucleic acid synthesis inhibition, enzymatic activities inhibition, and virulence factors inhibition. Thus, phytoconstituents have multitarget properties which make less probable the emergence of resistance than in case with standard antibiotics. In 2024, Abass et.al carried out an updated literature review regarding Anti-bacterial phytoconstituents. Authors focused their attention on mechanisms of action of alkaloids, flavonoids, terpenoids, coumarins, lignans, and phenolic acids. The review revealed that phytoconstituents interfere with quorum sensing, DNA replication, protein biosynthesis, and bacterial cell wall biosynthesis. Strong Anti-bacterial agents against multiresistant diseases are berberine, quercetin, catechin, thymol, and carvacrol. The most profound analysis of medicinal plants as a potential alternative to antibiotics was performed by El-Saadony et.al in 2025. Authors paid particular attention to Anti-bacterial bioactive constituents of Melaleuca alternifolia (terpinen-4-ol), Origanum vulgare (carvacrol), Azadirachta indica (azadirachtin), Curcuma longa (curcumin), and Allium sativum (allicin). These agents proved their ability to inhibit drug-resistant bacteria and fungi. Marappa and Gunashree studied antimicrobial bioactive agents from selected medicinal plants against drug-resistant bacteria in 2025. The authors established the main bioactive components to be phenolics, flavonoids, alkaloids, and terpenoids. It was shown that these bioactive molecules exhibit high Anti-bacterial activity towards methicillin resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Klebsiella pneumoniae. The study indicated that medicinal plants are excellent sources for developing antimicrobial drugs in the future.
Singh, et.al isolated and characterized new flavonoid structures from Nyctanthus arbor-tristis (Night Jasmine). Advanced spectroscopic methods were used to establish the structure of the isolated bioactive compounds. The isolated flavonoids showed significant Anti-bacterial activity against pathogenic strains of Escherichia coli and Staphylococcus aureus. These newly discovered bioactive molecules have been shown to possess drug-like properties, indicating their potential use as scaffolds for developing Anti-bacterial drugs. Flavonoids were shown in the study to be excellent bioactive scaffolds for developing new medicines for treating infections.
Patel, et.al. studied methanolic extracts of leaves from Cordia macleodii and established that there were two strong bioactive molecules, namely Tiliroside and Ouabain, using advanced chromatographic and spectroscopic techniques. The bioactive molecules exhibited potent Anti-bacterial activity against Enterococcus faecalis, an important bacterial strain associated with hospital acquired infections.
The extracts of five different medicinal plants were tested on selected pathogens by Palanisamy et al. (2024). Ethyl acetate extracts of Garcinia travancorica and chloroform extracts of Orthosiphon aristatus exhibited great antimicrobial potential. The presence of different phytoconstituents that were not known before was found via GC–MS analysis, which imparted the plants with Anti-bacterial and anticandidal properties.
In their systematic research conducted in 2024, Tiwana et al. analyzed the chemical composition of Phyllanthus niruri. Lignan, flavonoids, tannins, and phenolic chemicals having excellent Anti-bacterial properties have been discovered in the plant under consideration. Notably, the combination of those phytochemicals with the antibiotics improved antimicrobial effect against antibiotic-resistant bacteria. In 2025, Udensi et al. studied Anti-bacterial properties of three medicinal plants applied in folk medicine as a treatment of infections. High Anti-bacterial activity of phytochemicals containing flavonoids, terpenoids, and phenolics was established. It is worth noting that the fractions containing high amounts of citral had excellent Anti-bacterial activity due to the high content of flavonoids and phenolics in lemongrass (Cymbopogon citratus). A similar trend was observed in another important research performed by Ortega et al. in 2025. In total, there were 132 recently described Anti-bacterial metabolites isolated from the medicinal plants endophytic fungi. Notably, the activity of some endophytic microorganisms' products was equal to that of antibiotics. Another significant study by Daimari and Deka in 2024 was conducted on the production of bimetallic nanoparticles using leaf extract of Eryngium foetidum for the production of CuO–ZnO nanoparticles. The phytochemical components were utilized as stabilizing and reducing agents while forming the nanoparticles. The phyto-nanoparticles had more antimicrobial properties than those obtained by using crude extracts of phytochemicals against various bacteria species.
Table No.2 Emerging Novel Antimicrobial Phytoactives (2024–2025)
|
Phytoactive Compound |
Plant Source |
Antimicrobial Significance |
|
Tiliroside |
Cordia macleodii |
Active against Enterococcus faecalis |
|
α-Terpineol |
Myristica fragrans |
Anti-bacterial and antibiofilm activity |
|
4-Carvomenthenol |
Myristica fragrans |
Synergistic antimicrobial effects |
|
Carvacrol |
Origanum punonense |
Active against MRSA and MDR bacteria |
|
Citral |
Cymbopogon citratus |
Strong broad-spectrum Anti-bacterial activity |
|
Novel flavonoids |
Nyctanthus arbor-tristis |
Activity against S. aureus and E. coli |
|
Endophytic fungal metabolites |
Medicinal plant endophytes |
New antibiotic scaffolds |
|
Bioactive peptides |
Cuminum cyminum |
Emerging antimicrobial biomolecules |
7. Challenges and Future Directions
However, there are a number of issues that must be overcome in order to realize the potential of using bioactive phytochemicals as antimicrobial substances. First among these is the problem of standardization. Medicinal herbs are highly variable biological products, and the levels and combinations of bioactive phytoconstituents can differ greatly depending on various factors like their geographical sources, climatic conditions, period of harvest, and techniques employed during the extraction process. Consistency in the strength and purity of herbal medicines is crucial for their success in medical applications.
Figure No. 2: Represent Challenges associated with the antimicrobial potential of bioactive phytoconstituents from medicinal plants.
The diagram highlights major limitations including variability in phytochemical composition, poor bioavailability, toxicity concerns, lack of standardization, limited clinical evidence, and formulation difficulties that hinder their therapeutic application. Addressing these challenges is essential for the successful development of plant-derived antimicrobial agents.
A further important issue concerns the pharmacokinetic and pharmacodynamic profile of such drugs. It is essential for the definition of dosage and route of administration, as well as for avoiding undesirable effects such as drug interaction. A great number of plant-derived medicines exhibit poor bioavailability, which means that they are not easily absorbable by the organism, reducing their efficacy. In order to enhance bioavailability, various techniques are being used.
Clinical trials cannot be avoided in the development of any medication. Although in vitro and in vivo experiments conducted on laboratory animals help greatly in the understanding of medicinal processes, trials conducted directly on human beings are required in order to assess safety and efficacy.
Finally, resistance to such medicines may develop; however, it seems that such resistance will appear at a much slower rate compared to synthetic antimicrobial agents, as plant-based medicines employ a multifaceted mechanism.
Still, there are good prospects for future research and development efforts. Analytical methods, such as HPLC-MS and GC-MS technologies, help identify the chemical profiles and constituents' identity. High-throughput screening allows testing many plant extracts and purified compounds regarding their potential antimicrobial activity.
Identifying new targets and understanding the mechanism of antimicrobial action can be helped by genomics and bioinformatics tools. Further investigation of the combination of several phytoconstituents with other known antibiotics or among themselves might be helpful in overcoming resistance.
Development of new delivery methods, including those based on nanotechnology, will enhance bioavailability of phytoconstituents. Ethnobotanical information combined with scientific analysis becomes an efficient tool in searching for new drugs. Finally, regulatory policies will have to be reconsidered to facilitate the transition of phytomedicines into more scientifically based treatments.
CONCLUSION
The rising problem of resistance to antibiotics necessitates the rethinking of our treatment strategies for infectious diseases. Plant bioactives represent one of the most promising lines of research in this field. Their incredible variety and numerous antimicrobial targets make them a viable addition and alternative to synthetic drugs for dealing with dangerous bacteria. Alkaloids, flavonoids, terpenoids, glycosides, and other molecules found in medicinal plants are already known to show great efficacy against many pathogens and even antibiotic-resistant varieties.
Even though certain obstacles such as standardization and limited knowledge about bioavailability remain, continuous progress in the fields of analytical chemistry, pharmaceutics, and molecular biology creates a solid basis for developing plant bioactives into potent therapeutics. Moreover, the synergetic effects observed when combining different phytoconstituents along with those seen between different phytoconstituents and antibiotics are especially encouraging for the future of anti-infective treatments. Thus, by integrating both traditional experience and modern scientific discoveries in our approach to fighting diseases, we will be able to develop highly efficient antimicrobial drugs based on the components of medicinal plants.
ACKNOWLEDGEMENT
The authors want to acknowledge the research facilities and e-resources provided by Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur, C.G., India during the entire study process. The authors duly acknowledge classicclinicaltrials.com website for reference data for clinical study of drugs.
CONFLICTS OF INTEREST: The authors declare no competing interests.
FUNDING: The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
AUTHORS’ CONTRIBUTIONS: All authors reviewed the results and approved the final version of the manuscript.
REFERENCES
Animesh Mahato, Jayshri Sahu, Anushka Singh, Anshita Gupta, Bioactive Phytoconstituents of Medicinal Plants as Promising Antimicrobial Agents, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 9, 1252-1264. https://doi.org/10.5281/zenodo.22705054
10.5281/zenodo.22705054